跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,172 条关于
“ETA”
全部
5,172
临床试验
3,475
药物
819
机构
116
资讯
762
去年
Novel Evobody Bispecific Antibodies Show Promise in Ovarian Cancer by Targeting Vγ9Vδ2 T Cells
去年
BioCity's SC0062 Receives Breakthrough Therapy Designation for IgA Nephropathy
去年
BioCity's SC0062 Receives Second Breakthrough Therapy Designation for Diabetic Kidney Disease Treatment
去年
Atrasentan Receives FDA Accelerated Approval for IgA Nephropathy After Decades-Long Development Journey
去年
SC0062 Shows Promise in Reducing Proteinuria in IgA Nephropathy Patients
去年
Refining Pilot Trial Design: Three-Outcome Frameworks for Enhanced Decision-Making
去年
Gyre Therapeutics Initiates Phase 1 Trial of F230 for Pulmonary Arterial Hypertension in China
去年
Aprocitentan Demonstrates Efficacy in Treatment-Resistant Hypertension: PRECISION Trial Results
去年
IgA Nephropathy Pipeline Shows Strong Growth with 30+ Therapies in Development Across Multiple Clinical Stages
去年
Augurex Presents Novel 14-3-3eta Biomarker Data for Axial Spondyloarthritis Diagnosis at ACR Convergence 2025
第 1 页,共 77 页
上一页
下一页